Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of the Slit Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction

NCT03705000 is registered in ClinicalTrials.gov with Thomas Gardner as lead sponsor.

NCT NCT03705000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03705000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of the Slit Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction
Lead sponsor
Thomas Gardner
Phase
Not applicable
Overall status
Terminated
Start date
October 16, 2020
Completion date
May 11, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dacryocystorhinostomy, epiphora